Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts.

The article "Corrigendum: Radiosynthesis and in-vitro identification of a molecular probe 131I-FAPI targeting cancer-associated fibroblasts" published in Frontiers in Oncology on October 17, 2024, addresses an error in the affiliation of the authors. The correction clarifies that the Department of Nuclear Medicine is located at The Second Affiliated Hospital of Guangzhou Medical University in Guangzhou, Guangdong, China, not the First Affiliated Hospital. The authors emphasize that this correction does not impact the scientific conclusions of the original article. [Extracted from the article]